VT News

Renato Veiga

Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • NFL RedZone, known for its commercial-free coverage, will introduce full commercial breaks starting in the 2025 season, sparking backlash from viewers.
  • Bipartisan lawmakers propose bill to ban members of Congress and their families from trading individual stocks, aiming to address conflicts of interest and restore public trust.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • NFL RedZone, known for its commercial-free coverage, will introduce full commercial breaks starting in the 2025 season, sparking backlash from viewers.
  • Bipartisan lawmakers propose bill to ban members of Congress and their families from trading individual stocks, aiming to address conflicts of interest and restore public trust.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Renato Veiga

Top Topics

Trending in U.S.

World

Sport